ID SCN8A_MOUSE Reviewed; 1978 AA. AC Q9WTU3; Q3TYI3; Q60828; Q60858; Q62449; DT 15-AUG-2003, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1999, sequence version 1. DT 14-OCT-2015, entry version 127. DE RecName: Full=Sodium channel protein type 8 subunit alpha; DE AltName: Full=Sodium channel protein type VIII subunit alpha; DE AltName: Full=Voltage-gated sodium channel subunit alpha Nav1.6; GN Name=Scn8a; Synonyms=Nbna1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; OC Muroidea; Muridae; Murinae; Mus; Mus. OX NCBI_TaxID=10090 {ECO:0000312|EMBL:AAD20438.1}; RN [1] {ECO:0000305} RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3). RC STRAIN=C57BL/6J {ECO:0000312|EMBL:AAD20438.1}; RX PubMed=9828131; DOI=10.1006/geno.1998.5550; RA Plummer N.W., Galt J., Jones J.M., Burgess D.L., Sprunger L.K., RA Kohrman D.C., Meisler M.H.; RT "Exon organization, coding sequence, physical mapping, and polymorphic RT intragenic markers for the human neuronal sodium channel gene SCN8A."; RL Genomics 54:287-296(1998). RN [2] {ECO:0000305} RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND RP DISEASE. RC STRAIN=C57BL/6J {ECO:0000269|PubMed:7670495}; RC TISSUE=Brain {ECO:0000269|PubMed:7670495}; RX PubMed=7670495; DOI=10.1038/ng0895-461; RA Burgess D.L., Kohrman D.C., Galt J., Plummer N.W., Jones J.M., RA Spear B., Meisler M.H.; RT "Mutation of a new sodium channel gene, Scn8a, in the mouse mutant RT 'motor endplate disease'."; RL Nat. Genet. 10:461-465(1995). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-804, AND VARIANT LEU-5. RC STRAIN=C57BL/6J; TISSUE=Visual cortex; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., RA Davis M.J., Wilming L.G., Aidinis V., Allen J.E., RA Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., RA Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., RA Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., RA Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., RA di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., RA Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., RA Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., RA Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., RA Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., RA Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., RA Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., RA Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., RA Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., RA Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., RA Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., RA Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., RA Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., RA Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., RA Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., RA Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., RA Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., RA Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., RA Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., RA Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., RA Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., RA Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., RA Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., RA Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., RA Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., RA Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [4] {ECO:0000305} RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 93-205, AND DISEASE. RC STRAIN=129/Sv {ECO:0000269|PubMed:8663325}; RC TISSUE=Brain {ECO:0000269|PubMed:8663325}; RX PubMed=8663325; DOI=10.1074/jbc.271.29.17576; RA Kohrman D.C., Harris J.B., Meisler M.H.; RT "Mutation detection in the med and medJ alleles of the sodium channel RT Scn8a. Unusual splicing due to a minor class AT-AC intron."; RL J. Biol. Chem. 271:17576-17581(1996). RN [5] {ECO:0000305} RP NUCLEOTIDE SEQUENCE [MRNA] OF 1411-1686. RA Fan Z., Kyle J.W., Makielski J.C.; RT "A putative novel Na channel alpha subunit cDNA isolated from mouse RT NB2a neuroblastoma cells."; RL Submitted (MAR-1995) to the EMBL/GenBank/DDBJ databases. RN [6] RP INTERACTION WITH NEDD4 AND NEDD4L. RX PubMed=15123669; DOI=10.1074/jbc.M402820200; RA Fotia A.B., Ekberg J., Adams D.J., Cook D.I., Poronnik P., Kumar S.; RT "Regulation of neuronal voltage-gated sodium channels by the RT ubiquitin-protein ligases Nedd4 and Nedd4-2."; RL J. Biol. Chem. 279:28930-28935(2004). RN [7] {ECO:0000305} RP ALTERNATIVE SPLICING (ISOFORMS 1; 4 AND 5). RC TISSUE=Brain {ECO:0000269|PubMed:9295353}, and RC Fetal brain {ECO:0000269|PubMed:9295353}; RX PubMed=9295353; DOI=10.1074/jbc.272.38.24008; RA Plummer N.W., McBurney M.W., Meisler M.H.; RT "Alternative splicing of the sodium channel SCN8A predicts a truncated RT two-domain protein in fetal brain and non-neuronal cells."; RL J. Biol. Chem. 272:24008-24015(1997). RN [8] RP FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY. RX PubMed=19136557; DOI=10.1074/jbc.M801892200; RA Carrithers M.D., Chatterjee G., Carrithers L.M., Offoha R., RA Iheagwara U., Rahner C., Graham M., Waxman S.G.; RT "Regulation of podosome formation in macrophages by a splice variant RT of the sodium channel SCN8A."; RL J. Biol. Chem. 284:8114-8126(2009). RN [9] {ECO:0000305} RP VARIANT MEDJO THR-1317, AND VARIANT LEU-5. RC STRAIN=DBA/2WyDi {ECO:0000269|PubMed:8815882}; RX PubMed=8815882; RA Kohrman D.C., Smith M.R., Goldin A.L., Harris J., Meisler M.H.; RT "A missense mutation in the sodium channel Scn8a is responsible for RT cerebellar ataxia in the mouse mutant jolting."; RL J. Neurosci. 16:5993-5999(1996). RN [10] {ECO:0000305} RP DISEASE. RX PubMed=11532991; DOI=10.1093/hmg/10.17.1819; RA De Repentigny Y., Cote P.D., Pool M., Bernier G., Girard S., RA Vidal S.M., Kothary R.; RT "Pathological and genetic analysis of the degenerating muscle (dmu) RT mouse: a new allele of Scn8a."; RL Hum. Mol. Genet. 10:1819-1827(2001). CC -!- FUNCTION: Mediates the voltage-dependent sodium ion permeability CC of excitable membranes. Assuming opened or closed conformations in CC response to the voltage difference across the membrane, the CC protein forms a sodium-selective channel through which Na(+) ions CC may pass in accordance with their electrochemical gradient. In CC macrophages, isoform 5 may participate in the control of podosome CC and invadopodia formation. {ECO:0000269|PubMed:19136557}. CC -!- SUBUNIT: Interacts with FGF13; may regulate SCN8A activity (By CC similarity). Interacts with NEDD4 and NEDD4L. {ECO:0000250, CC ECO:0000269|PubMed:15123669}. CC -!- INTERACTION: CC P14873:Map1b; NbExp=7; IntAct=EBI-6396042, EBI-764653; CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19136557}; CC Multi-pass membrane protein {ECO:0000269|PubMed:19136557}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=5; CC Name=1 {ECO:0000269|PubMed:9295353, ECO:0000269|PubMed:9828131}; CC Synonyms=18A {ECO:0000269|PubMed:9295353}; CC IsoId=Q9WTU3-1; Sequence=Displayed; CC Name=2 {ECO:0000269|PubMed:7670495}; CC IsoId=Q9WTU3-2; Sequence=VSP_050594; CC Note=Due to aberrant splicing.; CC Name=3 {ECO:0000269|PubMed:9828131}; CC IsoId=Q9WTU3-3; Sequence=VSP_050595; CC Name=4 {ECO:0000269|PubMed:9295353}; Synonyms=18N CC {ECO:0000269|PubMed:9295353}; CC IsoId=Q9WTU3-4; Sequence=VSP_050596, VSP_050597; CC Name=5 {ECO:0000269|PubMed:9295353}; CC IsoId=Q9WTU3-5; Sequence=VSP_050598; CC -!- TISSUE SPECIFICITY: Expressed in brain, cerebellum and spinal CC cord. Isoform 5 may be expressed in non-neuronal tissues, such as CC peritoneal macrophages. {ECO:0000269|PubMed:19136557, CC ECO:0000269|PubMed:7670495}. CC -!- DOMAIN: The sequence contains 4 internal repeats, each with 5 CC hydrophobic segments (S1,S2,S3,S5,S6) and one positively charged CC segment (S4). Segments S4 are probably the voltage-sensors and are CC characterized by a series of positively charged amino acids at CC every third position. {ECO:0000305}. CC -!- PTM: May be ubiquitinated by NEDD4L; which would promote its CC endocytosis. {ECO:0000250}. CC -!- PTM: Phosphorylation at Ser-1495 by PKC in a highly conserved CC cytoplasmic loop slows inactivation of the sodium channel and CC reduces peak sodium currents. {ECO:0000250}. CC -!- DISEASE: Note=Defects in Scn8a are the cause of motor endplate CC disease (med). Med is a recessive neuromuscular disorder that is CC characterized by lack of signal transmission at the neuromuscular CC junction, excess preterminal arborization and degeneration of CC cerebellar Purkinje cells. It produces early onset progressive CC paralysis of hind limbs, severe muscle atrophy and juvenile CC lethality. CC -!- DISEASE: Note=Defects in Scn8a are the cause of the jolting mutant CC (medjo), a mild form of motor endplate disease which is CC characterized by the absence of spontaneous, regular, simple CC discharges from Purkinje cells. After 3 weeks of age, jolting mice CC are unsteady and have wide-based gait and a rhythmical tremor of CC head and neck induced by attempted movement. CC -!- DISEASE: Note=Defects in Scn8a are a cause of degenerating muscle CC (dmu). Dmu is an autosomal recessive neuromuscular disorder that CC is characterized by skeletal and cardiac muscle degeneration. It CC produces early onset progressive loss of mobility of the hind CC limbs and subsequent lethality in the first month of life. CC -!- SIMILARITY: Belongs to the sodium channel (TC 1.A.1.10) family. CC Nav1.6/SCN8A subfamily. {ECO:0000305}. CC -!- SIMILARITY: Contains 1 IQ domain. {ECO:0000255|PROSITE- CC ProRule:PRU00116, ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF049617; AAD20438.1; -; mRNA. DR EMBL; U26707; AAC52242.1; -; mRNA. DR EMBL; AK158609; BAE34580.1; -; mRNA. DR EMBL; U59964; AAC52708.1; -; Genomic_DNA. DR EMBL; U59963; AAC52708.1; JOINED; Genomic_DNA. DR EMBL; U23158; AAA65599.1; -; mRNA. DR CCDS; CCDS57011.1; -. [Q9WTU3-1] DR RefSeq; NP_001070967.1; NM_001077499.2. DR RefSeq; NP_035453.2; NM_011323.3. DR UniGene; Mm.385012; -. DR PDB; 3WFN; X-ray; 1.95 A; B/C/D/E=1893-1914. DR PDBsum; 3WFN; -. DR ProteinModelPortal; Q9WTU3; -. DR SMR; Q9WTU3; 1765-1911. DR BioGrid; 203103; 3. DR IntAct; Q9WTU3; 1. DR STRING; 10090.ENSMUSP00000080842; -. DR BindingDB; Q9WTU3; -. DR ChEMBL; CHEMBL1914275; -. DR GuidetoPHARMACOLOGY; 583; -. DR PhosphoSite; Q9WTU3; -. DR PaxDb; Q9WTU3; -. DR PRIDE; Q9WTU3; -. DR GeneID; 20273; -. DR KEGG; mmu:20273; -. DR CTD; 6334; -. DR MGI; MGI:103169; Scn8a. DR eggNOG; COG1226; -. DR HOGENOM; HOG000231755; -. DR HOVERGEN; HBG091796; -. DR InParanoid; Q9WTU3; -. DR KO; K04840; -. DR PhylomeDB; Q9WTU3; -. DR ChiTaRS; Scn8a; mouse. DR NextBio; 297955; -. DR PRO; PR:Q9WTU3; -. DR Proteomes; UP000000589; Unplaced. DR CleanEx; MM_SCN8A; -. DR Genevisible; Q9WTU3; MM. DR GO; GO:0030425; C:dendrite; IDA:MGI. DR GO; GO:0016020; C:membrane; IDA:MGI. DR GO; GO:0043025; C:neuronal cell body; IDA:MGI. DR GO; GO:0033268; C:node of Ranvier; IDA:BHF-UCL. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0034706; C:sodium channel complex; IPI:MGI. DR GO; GO:0001518; C:voltage-gated sodium channel complex; IC:UniProtKB. DR GO; GO:0030018; C:Z disc; IDA:BHF-UCL. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0005248; F:voltage-gated sodium channel activity; NAS:UniProtKB. DR GO; GO:0008344; P:adult locomotory behavior; IMP:MGI. DR GO; GO:0007628; P:adult walking behavior; IMP:MGI. DR GO; GO:0007626; P:locomotory behavior; IMP:MGI. DR GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central. DR GO; GO:0007517; P:muscle organ development; IMP:MGI. DR GO; GO:0050905; P:neuromuscular process; IMP:MGI. DR GO; GO:0019228; P:neuronal action potential; IBA:GO_Central. DR GO; GO:0009636; P:response to toxic substance; IDA:MGI. DR GO; GO:0007605; P:sensory perception of sound; IMP:MGI. DR GO; GO:0035725; P:sodium ion transmembrane transport; ISO:MGI. DR GO; GO:0006814; P:sodium ion transport; NAS:UniProtKB. DR Gene3D; 1.20.120.350; -; 4. DR InterPro; IPR027359; Channel_four-helix_dom. DR InterPro; IPR024583; DUF3451. DR InterPro; IPR005821; Ion_trans_dom. DR InterPro; IPR000048; IQ_motif_EF-hand-BS. DR InterPro; IPR008054; Na_channel_a8su. DR InterPro; IPR001696; Na_channel_asu. DR InterPro; IPR010526; Na_trans_assoc. DR PANTHER; PTHR10037:SF132; PTHR10037:SF132; 1. DR Pfam; PF00520; Ion_trans; 4. DR Pfam; PF00612; IQ; 1. DR Pfam; PF06512; Na_trans_assoc; 1. DR Pfam; PF11933; Na_trans_cytopl; 1. DR PRINTS; PR00170; NACHANNEL. DR PRINTS; PR01667; NACHANNEL8. DR SMART; SM00015; IQ; 1. DR PROSITE; PS50096; IQ; 1. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; ATP-binding; Complete proteome; KW Disease mutation; Glycoprotein; Ion channel; Ion transport; Membrane; KW Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome; KW Repeat; Sodium; Sodium channel; Sodium transport; Transmembrane; KW Transmembrane helix; Transport; Ubl conjugation; KW Voltage-gated channel. FT CHAIN 1 1978 Sodium channel protein type 8 subunit FT alpha. FT /FTId=PRO_0000048501. FT TOPO_DOM 1 127 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 128 151 Helical; Name=S1 of repeat I. FT {ECO:0000255}. FT TOPO_DOM 152 159 Extracellular. {ECO:0000255}. FT TRANSMEM 160 179 Helical; Name=S2 of repeat I. FT {ECO:0000255}. FT TOPO_DOM 180 192 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 193 211 Helical; Name=S3 of repeat I. FT {ECO:0000255}. FT TOPO_DOM 212 217 Extracellular. {ECO:0000255}. FT TRANSMEM 218 237 Helical; Name=S4 of repeat I. FT {ECO:0000255}. FT TOPO_DOM 238 252 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 253 277 Helical; Voltage-sensor; Name=S5 of FT repeat I. {ECO:0000255}. FT TOPO_DOM 278 387 Extracellular. {ECO:0000255}. FT TRANSMEM 388 413 Helical; Name=S6 of repeat I. FT {ECO:0000255}. FT TOPO_DOM 414 745 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 746 770 Helical; Name=S1 of repeat II. FT {ECO:0000255}. FT TOPO_DOM 771 781 Extracellular. {ECO:0000255}. FT TRANSMEM 782 805 Helical; Name=S2 of repeat II. FT {ECO:0000255}. FT TOPO_DOM 806 813 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 814 833 Helical; Name=S3 of repeat II. FT {ECO:0000255}. FT TOPO_DOM 834 839 Extracellular. {ECO:0000255}. FT TRANSMEM 840 860 Helical; Voltage-sensor; Name=S4 of FT repeat II. {ECO:0000255}. FT TOPO_DOM 861 875 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 876 896 Helical; Name=S5 of repeat II. FT {ECO:0000255}. FT TOPO_DOM 897 949 Extracellular. {ECO:0000255}. FT TRANSMEM 950 975 Helical; Name=S6 of repeat II. FT {ECO:0000255}. FT TOPO_DOM 976 1191 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 1192 1215 Helical; Name=S1 of repeat III. FT {ECO:0000255}. FT TOPO_DOM 1216 1228 Extracellular. {ECO:0000255}. FT TRANSMEM 1229 1254 Helical; Name=S2 of repeat III. FT {ECO:0000255}. FT TOPO_DOM 1255 1260 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 1261 1282 Helical; Name=S3 of repeat III. FT {ECO:0000255}. FT TOPO_DOM 1283 1286 Extracellular. {ECO:0000255}. FT TRANSMEM 1287 1308 Helical; Voltage-sensor; Name=S4 of FT repeat III. {ECO:0000255}. FT TOPO_DOM 1309 1327 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 1328 1349 Helical; Name=S5 of repeat III. FT {ECO:0000255}. FT TOPO_DOM 1350 1435 Extracellular. {ECO:0000255}. FT TRANSMEM 1436 1462 Helical; Name=S6 of repeat III. FT {ECO:0000255}. FT TOPO_DOM 1463 1515 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 1516 1539 Helical; Name=S1 of repeat IV. FT {ECO:0000255}. FT TOPO_DOM 1540 1550 Extracellular. {ECO:0000255}. FT TRANSMEM 1551 1574 Helical; Name=S2 of repeat IV. FT {ECO:0000255}. FT TOPO_DOM 1575 1580 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 1581 1604 Helical; Name=S3 of repeat IV. FT {ECO:0000255}. FT TOPO_DOM 1605 1614 Extracellular. {ECO:0000255}. FT TRANSMEM 1615 1636 Helical; Voltage-sensor; Name=S4 of FT repeat IV. {ECO:0000255}. FT TOPO_DOM 1637 1651 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 1652 1674 Helical; Name=S5 of repeat IV. FT {ECO:0000255}. FT TOPO_DOM 1675 1739 Extracellular. {ECO:0000255}. FT TRANSMEM 1740 1764 Helical; Name=S6 of repeat IV. FT {ECO:0000255}. FT TOPO_DOM 1765 1978 Cytoplasmic. {ECO:0000255}. FT REPEAT 114 442 I. {ECO:0000305}. FT REPEAT 733 1005 II. {ECO:0000305}. FT REPEAT 1178 1493 III. {ECO:0000305}. FT REPEAT 1502 1799 IV. {ECO:0000305}. FT DOMAIN 1893 1922 IQ. {ECO:0000255|PROSITE- FT ProRule:PRU00116, ECO:0000305}. FT NP_BIND 891 898 ATP. {ECO:0000255}. FT MOD_RES 518 518 Phosphoserine. FT {ECO:0000250|UniProtKB:O88420}. FT MOD_RES 520 520 Phosphoserine. FT {ECO:0000250|UniProtKB:O88420}. FT MOD_RES 1495 1495 Phosphoserine; by PKC. {ECO:0000250}. FT CARBOHYD 215 215 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 289 289 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 295 295 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 308 308 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 326 326 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 1356 1356 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 1370 1370 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 1381 1381 N-linked (GlcNAc...). {ECO:0000255}. FT VAR_SEQ 428 673 Missing (in isoform 2). FT {ECO:0000303|PubMed:7670495}. FT /FTId=VSP_050594. FT VAR_SEQ 664 664 E -> EVKIDKAATDS (in isoform 3). FT {ECO:0000303|PubMed:9828131}. FT /FTId=VSP_050595. FT VAR_SEQ 1272 1312 Missing (in isoform 5). FT {ECO:0000303|PubMed:9295353}. FT /FTId=VSP_050598. FT VAR_SEQ 1273 1280 SLVSLIAN -> PLSLSGLI (in isoform 4). FT {ECO:0000303|PubMed:9295353}. FT /FTId=VSP_050596. FT VAR_SEQ 1281 1978 Missing (in isoform 4). FT {ECO:0000303|PubMed:9295353}. FT /FTId=VSP_050597. FT VARIANT 5 5 V -> L. {ECO:0000269|PubMed:16141072, FT ECO:0000269|PubMed:8815882}. FT VARIANT 1317 1317 A -> T (in medjo). FT {ECO:0000269|PubMed:8815882}. FT CONFLICT 207 207 V -> I (in Ref. 3; BAE34580). FT {ECO:0000305}. FT CONFLICT 212 212 D -> N (in Ref. 3; BAE34580). FT {ECO:0000305}. FT CONFLICT 554 554 P -> T (in Ref. 3; BAE34580). FT {ECO:0000305}. FT CONFLICT 596 596 G -> D (in Ref. 3; BAE34580). FT {ECO:0000305}. FT CONFLICT 1498 1498 P -> A (in Ref. 5; AAA65599). FT {ECO:0000305}. FT CONFLICT 1504 1504 R -> E (in Ref. 5; AAA65599). FT {ECO:0000305}. FT HELIX 1893 1912 {ECO:0000244|PDB:3WFN}. SQ SEQUENCE 1978 AA; 225141 MW; 9EA4A8E610707220 CRC64; MAARVLAPPG PDSFKPFTPE SLANIERRIA ESKLKKPPKA DGSHREDDED SKPKPNSDLE AGKSLPFIYG DIPQGLVAVP LEDFDPYYLT QKTFVVLNRG KTLFRFSATP ALYILSPFNL IRRIAIKILI HSVFSMIIMC TILTNCVFMT FSNPPEWSKN VEYTFTGIYT FESLVKIIAR GFCIDGFTFL RDPWNWLDFS VIMMAYVTEF VDLGNVSALR TFRVLRALKT ISVIPGLKTI VGALIQSVKK LSDVMILTVF CLSVFALIGL QLFMGNLRNK CVVWPINFNE SYLENGTRGF DWEEYINNKT NFYMVPGMLE PLLCGNSSDA GQCPEGFQCM KAGRNPNYGY TSFDTFSWAF LALFRLMTQD YWENLYQLTL RAAGKTYMIF FVLVIFVGSF YLVNLILAVV AMAYEEQNQA TLEEAEQKEA EFKAMLEQLK KQQEEAQAAA MATSAGTVSE DAIEEEGEDG VGSPRSSSEL SKLSSKSAKE RRNRRKKRKQ KELSEGEEKG DPEKVFKSES EDGMRRKAFR LPDNRIGRKF SIMNQSLLSI PGSPFLSRHN SKSSIFSFRG PGRFRDPGSE NEFADDEHST VEESEGRRDS LFIPIRARER RSSYSGYSGY SQCSRSSRIF PSLRRSVKRN STVDCNGVVS LIGPGSHIGR LLPEATTEVE IKKKGPGSLL VSMEQLASYG RKDRINSIMS VVTNTLVEEL EESQRKCPPC WYKFANTFLI WECHPYWIKL KEIVNLIVMD PFVDLAITIC IVLNTLFMAM EHHPMTPQFE HVLAVGNLVF TGIFTAEMFL KLIAMDPYYY FQEGWNIFDG FIVSLSLMEL GLADVEGLSV LRSFRLLRVF KLAKSWPTLN MLIKIIGNSV GALGNLTLVL AIIVFIFAVV GMQLFGKSYK ECVCKISQEC KLPRWHMNDF FHSFLIVFRV LCGEWIETMW DCMEVAGQAM CLIVFMMVMV IGNLVVLNLF LALLLSSFSA DNLAATDDDG EMNNLQISVI RIKKGVAWAK VKVHAFMQAH FKQREADEVK PLDELYEKKA NCIANHTGVD IHRNGDFQKN GNGTTSGIGS SVEKYIIDED HMSFINNPNL TVRVPIAVGE SDFENLNTED VSSESDPEGS KDKLDDTSSS EGSTIDIKPE VEEVPVEQPE EYLDPDACFT EGCVQRFKCC QVNIEEGLGK SWWILRKTCF LIVEHNWFET FIIFMILLSS GALAFEDIYI EQRKTIRTIL EYADKVFTYI FILEMLLKWT AYGFVKFFTN AWCWLDFLIV AVSLVSLIAN ALGYSELGAI KSLRTLRALR PLRALSRFEG MRVVVNALVG AIPSIMNVLL VCLIFWLIFS IMGVNLFAGK YHYCFNETSE IRFEIDEVNN KTDCEKLMEG NNTEIRWKNV KINFDNVGAG YLALLQVATF KGWMDIMYAA VDSRKPDEQP DYEGNIYMYI YFVIFIIFGS FFTLNLFIGV IIDNFNQQKK KFGGQDIFMT EEQKKYYNAM KKLGSKKPQK PIPRPLNKIQ GIVFDFVTQQ AFDIVIMMLI CLNMVTMMVE TDTQSKQMEN ILYWINLVFV IFFTCECVLK MFALRHYYFT IGWNIFDFVV VILSIVGMFL ADIIEKYFVS PTLFRVIRLA RIGRILRLIK GAKGIRTLLF ALMMSLPALF NIGLLLFLVM FIFSIFGMSN FAYVKHEAGI DDMFNFETFG NSMICLFQIT TSAGWDGLLL PILNRPPDCS LDKEHPGSGF KGDCGNPSVG IFFFVSYIII SFLIVVNMYI AIILENFSVA TEESADPLSE DDFETFYEIW EKFDPDATQF IEYCKLADFA DALEHPLRVP KPNTIELIAM DLPMVSGDRI HCLDILFAFT KRVLGDSGEL DILRQQMEER FVASNPSKVS YEPITTTLRR KQEEVSAVVL QRAYRGHLAR RGFICRKITS NKLENGGTHR EKKESTPSTA SLPSYDSVTK PDKEKQQRAE EGRRERAKRQ KEVRESKC //